Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00500435 · ClinicalTrials.gov registry record
Extraperitoneal Lymph Node Dissection in Patients With Cervical Cancer
A clinical trial of Cervical Cancer, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 65
- Enrollment target
- 2
- Study locations
NCT00500435 is a study of Cervical Cancer that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 65 participants, below the 570-participant average among 144 other Cervical Cancer trials with a reported enrollment target (89% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT00500435, a study of Cervical Cancer, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 65 participants
- Enrollment target
- 2
- Study locations
Study Summary
Primary Objectives: * To determine the feasibility of performing an extraperitoneal laparoscopic lymphadenectomy in patients with stage IB2-IVA cervical carcinoma who are dispositioned to undergo radiotherapy and concurrent chemotherapy. * To document intraoperative and postoperative complications in patients undergoing extraperitoneal laparoscopic lymphadenectomy. * To determine the rate of lymph node metastases in the para-aortic region in patients with stage IB2-IVA cervical cancer. * To correlate histopathological findings in the para-aortic lymph nodes with preoperative imaging studies (Positron emission tomography (PET) and magnetic resonance imaging (MRI) and computed tomography (CT)).
Conditions Studied
Interventions
- PROCEDURE Extraperitoneal Laparoscopic Lymphadenectomy
Study Locations (2)
Texas
- Lyndon Baines Johnson General Hospital - Houston
- UT MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2003-10 |
| Est. Completion | 2011-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00500435
The ClinicalTrials.gov registry entry for NCT00500435 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 570-participant average among 144 other Cervical Cancer trials with a reported enrollment target (89% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cervical Cancer appearing as the primary indexed condition, and to 1 intervention - of which Extraperitoneal Laparoscopic Lymphadenectomy is the first listed.
NCT00500435 reports 2 study locations spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT00500435 about?
NCT00500435 is a clinical study titled "Extraperitoneal Lymph Node Dissection in Patients With Cervical Cancer". Primary Objectives: * To determine the feasibility of performing an extraperitoneal laparoscopic lymphadenectomy in patients with stage IB2-IVA cervical carcinoma who are dispositioned to undergo radiotherapy and concurrent chemotherapy. * To document intraoperative and postoperative complications ...
What is the current status of trial NCT00500435?
This trial is currently completed. The enrollment target is 65 participants. The study started on 2003-10. Estimated completion is 2011-05.
What conditions does trial NCT00500435 study?
This clinical trial studies the following conditions: Cervical Cancer.
What interventions are being tested in trial NCT00500435?
The interventions under investigation include: Extraperitoneal Laparoscopic Lymphadenectomy (PROCEDURE).
Who is sponsoring clinical trial NCT00500435?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00500435 being conducted?
This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cervical Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Biological Drivers of Cervical Cancer and Side Effects From Radiation Therapy
RECRUITING
-
PRGN-2009 in Combination With Pembrolizumab Versus Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer
RECRUITING · Phase 2
-
Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
RECRUITING · Phase 2
-
KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer
RECRUITING · Phase 1
-
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
RECRUITING · Phase 1
-
PopSci CHW4CervixHealth
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.